Searched for
API MAKERS
Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- Time to think of the repair cycle? 8 engineering stocks from India’s capital goods ecosystem with upside potential of up to 26%At a time when the markets are focused on war, crude oil, inflation, and supply disruption, it is easy to miss a quieter shift. India’s eng...
- Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
- OpenAI unveils three audio models for real-time voice tasksOpenAI has unveiled three new audio models for developers. These models aim to make voice agents more interactive and capable of real-time ...
- Google signs classified AI deal with Pentagon: ReportGoogle has joined other tech firms in a deal with the US Department of Defense. The agreement allows the Pentagon to use Google's AI for la...
- Google signs classified AI deal with Pentagon: The InformationGoogle has inked a deal with the U.S. Department of Defense, allowing the Pentagon to utilise its AI models for classified government work....
- After tariff wars, Trump is opening a new front in US-China rivalryThe US accuses China of stealing AI intellectual property, escalating the tech rivalry beyond tariffs. This move, potentially impacting chi...
- Did this recently-listed smallcap stock really crash 90% in one day? Here's why you should ignore the plungeAnlon Healthcare shares appeared to crash nearly 90% in a single session, but the fall was due to adjustments following a 1:1 bonus issue a...
- OpenAI, Microsoft expand cybersecurity partnership amid rising AI threatsOpenAI and Microsoft are joining forces to combat cyber threats. They will deploy advanced artificial intelligence tools to enhance securit...
- Bonus issue & stock split: Last day to buy shares of this smallcap company before record date. Do you own?Anlon Healthcare's shares will trade ex-record date tomorrow for its 1:1 bonus issue and 1:5 stock split, making today the last chance for ...
- OpenAI identifies security issue involving third-party tool, says user data was not accessedOpenAI said on Friday it had identified a security issue involving a third-party developer tool called Axios and is taking steps to protect...
- Rising costs of key chemicals choke production at drug ingredient makersIndia's bulk-drug manufacturers are facing a severe cost crisis as prices of key solvents and intermediates have surged due to supply disru...
- API maker Fleming Laboratories raises Rs 110 cr from PE fund InvAscentFleming is a backward integrated API manufacturer with global leadership in select muscle relaxant, anti-arthritis, and antihistamine APIs ...
- Indian API makers benefit as global buyers ditch ChinaPrice sensitivity among formulation companies is declining amid a receding threat of supply chain disruptions from Chinese suppliers, which...
- Indian drug firms cheer dexamethasone efficacy on severe COVID-19 patientsM P Gupta, general manager of Mahima Lifesciences, a Chandigarh-based steroid API maker, said the company was expecting a jump in raw mater...
- Drug makers manage to up mfg capacity to 50-60%A major challenge is congestion at ports, which may lead to shortages of key starting materials and active pharmaceutical ingredients (APIs...
- Orchid gets three final bids at par with liquidation valueThe company had to sell assets to rein in debt. In 2012, it sold its penicillin business to US drug maker Hospira for $200 million.
- Arch Pharmalabs becomes a leading API makerBorn out of an ailing pharma company, Arch Pharmalabs is now a leading API maker.
- Indian pharmas increase API imports from ChinaEven as Indian active pharmaceutical ingredients (API) makers compete with Chinese companies globally, growing API imports from China to In...
Load More
